• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

NOVEL 1, 5-BENZOTHIAZEPINES: SYNTHESIS, CHARACTERIZATION, AND CYTOTOXICITY STUDIES

    Praveen Kumar Borra, Phool Chandra, Vidyadhara Suryadevara, Neetu Sachan

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 5532-5546

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Fifteen benzothiazepine compounds were synthesized and their cytotoxicity was studied because of the significance of the benzothiazepine pharmacophore. Benzothiazepines were synthesised by combined 0.01 mol of 1,3-substituted prop-2-en-1-one, 0.01 mol of 2-aminothiophenol, 1.25 ml of water, and a pinch of zinc acetate as a catalyst in a conical flask. The solvent free reaction mixture was heated in a microwave oven for 2-3 minutes at a temperature of 80-85OC. Products were filtered, dried, and recrystallized in ethanol after being washed in water to remove the catalyst. The compounds' characterization was done using the IR, NMR and Mass spectroscopy. The in vivo cytotoxicity studies were performed using MTT assay method. Spectral data reveals the structure of the compound benzothiazepine. Of all the compounds tested against HT-29 cell lines, the compound BT-09 having a nitrophenyl moiety in its structure showed maximum activity with a IC50 value of 28 µg/mL. Among the compounds tested for cytotoxicity on MCF-7 cell lines, the compound BT-09 showed maximum activity (IC50 27 µg/mL). Among the compounds tested for cytotoxicity on DU-145 cell lines, the compounds, BT-09 and BT-11 showed maximum activity (IC50 16 µg/mL). It was also observed that most of the compounds tested on these three cell lines showed maximum activity on prostate cancer cell lines (DU-145). The cytotoxic results showed that the compound BT-09 with a nitrophenyl moiety in its structure was the most effective against the HT-29 cell line, MCF-7 cell line, and DU-145 cell line, with an IC50 value of 28 g/mL, 27 g/mL, and 16 g/mL, respectively
Keywords:
    Benzothiazepines o-Amino thiophenol Zinc acetate Cytotoxicity MTT assay
  • PDF (495 K)
  • XML
(2022). NOVEL 1, 5-BENZOTHIAZEPINES: SYNTHESIS, CHARACTERIZATION, AND CYTOTOXICITY STUDIES. European Journal of Molecular & Clinical Medicine, 9(7), 5532-5546.
Praveen Kumar Borra, Phool Chandra, Vidyadhara Suryadevara, Neetu Sachan. "NOVEL 1, 5-BENZOTHIAZEPINES: SYNTHESIS, CHARACTERIZATION, AND CYTOTOXICITY STUDIES". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 5532-5546.
(2022). 'NOVEL 1, 5-BENZOTHIAZEPINES: SYNTHESIS, CHARACTERIZATION, AND CYTOTOXICITY STUDIES', European Journal of Molecular & Clinical Medicine, 9(7), pp. 5532-5546.
NOVEL 1, 5-BENZOTHIAZEPINES: SYNTHESIS, CHARACTERIZATION, AND CYTOTOXICITY STUDIES. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 5532-5546.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 33
  • PDF Download: 26
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus